Therapeutic Results in Elderly Patients with Prostate Cancer: Chronological Comparison in a Single Community Hospital

Overview

Journal J Rural Med

Date 2016 Dec 9

PMID 27928457

Citations 1

Authors

Takehiko Okamura

Hidetoshi Akita

Kenji Yamada

Daichi Kobayashi

Yasuhiko Hirose

Takahiro Kobayashi

Yutaro Tanaka

Taku Naiki

Takahiro Yasui

Affiliations

Soon will be listed here.

Abstract

There are few reports of the long-term outcomes of elderly patients with prostate cancer. We analyzed data from our institution from the past 12 years, including the patient history, treatment methods, and prognosis of patients with prostate cancer aged 80 years or more. A total of 179 cases of prostate cancer in patients aged 80 years or more were retrospectively evaluated. We divided them chronologically into groups A, B, C, and D: Group A included 40 cases from 2002-2004; Group B, 48 cases from 2005-2007; Group C, 46 cases from 2008-2010; and Group D, 45 cases from 2011-2013. Sixty-one (30%) patients changed treatment course. Interestingly, no cancer deaths occurred in the patients who changed treatment course. Although 14 (7.8%) cancer deaths occurred (A: B: C: D = 4: 4: 6: 0, respectively), all occurred in 2011 or later. In our study, over 50 patients who underwent treatment survived for 5 years or more. By treating prostate cancer in elderly patients when appropriate, we can lower the mortality rate due to prostate cancer. Our results support the active treatment of prostate cancer in elderly patients.

Citing Articles

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac.

Junco J, Rodriguez R, Fuentes F, Baladron I, Castro M, Calzada L Front Oncol. 2019; 9:49.

PMID: 30859088 PMC: 6397853. DOI: 10.3389/fonc.2019.00049.

References

Ficarra V, Novara G, Ahlering T, Costello A, Eastham J, Graefen M . Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012; 62(3):418-30. DOI: 10.1016/j.eururo.2012.05.046. View

Hoppe B, Bryant C, Sandler H . Radiation for prostate cancer: intensity modulated radiation therapy versus proton beam. J Urol. 2015; 193(4):1089-91. DOI: 10.1016/j.juro.2015.01.069. View

Kunz I, Musch M, Roggenbuck U, Klevecka V, Kroepfl D . Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy. BJU Int. 2012; 111(3 Pt B):E24-9. DOI: 10.1111/j.1464-410X.2012.11368.x. View

Fujimoto H, Nakanishi H, Miki T, Kubota Y, Takahashi S, Suzuki K . Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA. Int J Urol. 2011; 18(12):876-81. DOI: 10.1111/j.1442-2042.2011.02895.x. View

Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K . A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci. 2004; 95(3):238-42. PMC: 11159243. DOI: 10.1111/j.1349-7006.2004.tb02209.x. View

Ploussard G, De La Taille A, Moulin M, Vordos D, Hoznek A, Abbou C . Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy. Eur Urol. 2012; 65(3):610-9. DOI: 10.1016/j.eururo.2012.11.049. View

Evans J, Zhao S, Daignault S, Sanda M, Michalski J, Sandler H . Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol. 2015; 116(2):179-84. DOI: 10.1016/j.radonc.2015.07.016. View

Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N . Changes in indications and oncological outcomes of radical prostatectomy after 2000--data from 1268 Japanese patients treated with radical prostatectomy between 2000 and 2009. Jpn J Clin Oncol. 2013; 43(8):821-6. DOI: 10.1093/jjco/hyt072. View

Gillessen S, Omlin A, Attard G, de Bono J, Efstathiou E, Fizazi K . Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Ann Oncol. 2015; 26(8):1589-604. PMC: 4511225. DOI: 10.1093/annonc/mdv257. View

10.

Pierorazio P, Humphreys E, Walsh P, Partin A, Han M . Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians. BJU Int. 2010; 106(6):791-5. DOI: 10.1111/j.1464-410X.2010.09239.x. View

11.

Alvarez-Cubero M, Pascual-Geler M, Rivas A, Martinez-Gonzalez L, Saiz M, Lorente J . Lifestyle and dietary factors in relation to prostate cancer risk. Int J Food Sci Nutr. 2015; 66(7):805-10. DOI: 10.3109/09637486.2015.1077786. View

12.

Bell L, Cox J, Eade T, Rinks M, Herschtal A, Kneebone A . Determining optimal planning target volume and image guidance policy for post-prostatectomy intensity modulated radiotherapy. Radiat Oncol. 2015; 10:151. PMC: 4514953. DOI: 10.1186/s13014-015-0467-8. View